- Home
- MNPR vs ESP Comparison
MNPR vs ESP Comparison
Compare MNPR & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | ESP |
|---|---|---|
| Founded | 2014 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 148.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNPR | ESP |
|---|---|---|
| Price | $70.95 | $44.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $97.83 | N/A |
| AVG Volume (30 Days) | ★ 163.8K | 15.8K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | N/A | ★ 28.72 |
| EPS | N/A | ★ 3.16 |
| Revenue | N/A | ★ $42,600,530.00 |
| Revenue This Year | N/A | $9.16 |
| Revenue Next Year | N/A | $5.68 |
| P/E Ratio | ★ N/A | $13.74 |
| Revenue Growth | N/A | ★ 4.90 |
| 52 Week Low | $21.00 | $24.85 |
| 52 Week High | $105.00 | $55.00 |
Technical Indicators
Market Signals| Indicator | MNPR | ESP |
|---|---|---|
| Relative Strength Index (RSI) | 38.06 | 61.14 |
| Support Level | $73.63 | $41.30 |
| Resistance Level | $77.45 | $45.00 |
| Average True Range (ATR) | 5.49 | 1.69 |
| MACD | -1.01 | 0.41 |
| Stochastic Oscillator | 13.30 | 70.20 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.